The Society for Gastroenterology Nurses and Associates (SGNA) launched a nurse fellowship program in 2011 to promote evidence-based practice. Each accepted applicant was challenged to select a relevant topic, explore the current research, and translate this information to daily practice. The author, an SGNA Fellow, selected the topic, nurse-administered propofol sedation, that has been a prevailing subject in endoscopy for many years. A significant amount of literature has been written on the drug's safety and efficacy. This article explores a brief history of the practice and the future of this controversial drug for procedural sedation. A review of current literature is explored with an emphasis on the past 5 years as well as a discussion on regulatory limitations that have been placed on the practice of non-anesthesiologist-administered propofol sedation.
Beth Rivera, BSN, RN, CGRN, is Unit Director for Endoscopy/Outpatient/PAT/OR Holding, Sierra Medical Center, El Paso, TX.
Correspondence to: Beth Rivera, BSN, RN, CGRN, Sierra Medical Center, 1625 Medical Center Drive, El Paso, TX 79902 (firstname.lastname@example.org)
The author declares no conflicts of interest.
Received September 25, 2013
Accepted December 31, 2013